ClinicalTrials.gg
Active, not recruitingNCT07908394Updated Nov 2, 2026

THE EFFECT OF FILLING MATERIAL AND PLACEMENT TECHNIQUE ON POSTOPERATIVE PAIN IN NON-SURGICAL ENDODONTIC RETREATMENT: A RANDOMIZED CLINICAL TRIAL

An interventional study of BioMTA+ and Well-Root PT in Retreatment and Endodontic Diseases, sponsored by TC Erciyes University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2026, registered Oct 2026).
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Postoperative pain is a common concern following root canal retreatment. The type of root canal filling material and the technique used to place it may influence pain experienced after treatment.

This randomized clinical trial aims to compare the effects of two calcium silicate-based root canal filling materials (BioMTA+ and Well-Root PT) and two placement techniques (manual compaction and reverse-rotation compaction) on postoperative pain following nonsurgical endodontic retreatment.

A total of 56 adult patients requiring root canal retreatment due to persistent inflammation around the root tip will be randomly assigned to four treatment groups. All procedures will be performed in a single visit.

Postoperative pain will be evaluated using a visual analog scale (VAS), and the use of pain-relieving medication will be recorded.

The study aims to determine whether the type of filling material, the placement technique, or their combination influences postoperative pain following nonsurgical root canal retreatment.

Read the detailed description

Postoperative pain is an important clinical outcome following nonsurgical endodontic retreatment and may be influenced by several factors, including periapical inflammation, mechanical instrumentation, irrigation procedures, root canal filling materials, and obturation techniques.

In endodontic retreatment cases involving loss of apical constriction, achieving adequate apical adaptation and retention of conventional gutta-percha may be challenging. Calcium silicate-based materials have been introduced as alternative filling materials because of their biocompatibility, bioactivity, and sealing properties. However, clinical evidence regarding the influence of different calcium silicate-based materials and their placement techniques on postoperative pain remains limited.

The objective of this prospective, randomized, parallel-group clinical trial is to compare postoperative pain following single-visit nonsurgical endodontic retreatment using two calcium silicate-based filling materials, BioMTA+ and Well-Root PT, applied with either manual compaction or reverse-rotation compaction.

The study will be conducted at the Department of Endodontics, Faculty of Dentistry, Erciyes University, Türkiye.

A total of 56 patients requiring nonsurgical endodontic retreatment of previously treated single-rooted permanent teeth with chronic apical periodontitis will be included.

Following written informed consent, participants will be randomly allocated into four groups, with 14 patients in each group:

Group 1: BioMTA+ with manual compaction.

Group 2: BioMTA+ with reverse-rotation compaction.

Group 3: Well-Root PT with manual compaction.

Group 4: Well-Root PT with reverse-rotation compaction.

Randomization will be performed using a computer-generated randomization sequence. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. Participants will be blinded to the filling material used; however, operator blinding will not be possible because of the nature of the interventions.

All endodontic retreatment procedures will be performed in a single visit under local anesthesia and rubber dam isolation. Existing root canal filling materials will be removed, and working length will be established using an electronic apex locator and confirmed radiographically.

Root canals will be instrumented using rotary nickel-titanium instruments, with final preparation to size 40/.04. Irrigation will be performed using 5% sodium hypochlorite and 17% ethylenediaminetetraacetic acid (EDTA), followed by final irrigation and drying with paper points.

Depending on group allocation, root canals will be completely filled with either BioMTA+ or Well-Root PT using one of the following placement techniques:

Manual Compaction: The filling material will be introduced into the root canal and compacted using a manual endodontic plugger positioned approximately 1-2 mm short of the working length. Controlled compaction will be performed from the apical toward the coronal region.

Reverse-Rotation Compaction: The filling material will be introduced into the root canal and compacted using a 40/.04 nickel-titanium rotary instrument operated in reverse rotation at 100 rpm. The instrument will be positioned approximately 1 mm short of the working length and activated using controlled movements.

Following obturation, radiographic evaluation will be performed to assess the root canal filling. The coronal restoration will then be completed.

Postoperative pain intensity will be assessed using a visual analog scale (VAS) at predetermined postoperative time points. Patients will be instructed to

02

Conditions studied

  • Retreatment
  • Endodontic Diseases

Browse trials for

Keywords

  • RETREATMENT
  • POSTOPERATIVE PAIN
  • Calcium Silicate-Based Materials
  • Reverse-Rotation Compaction
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 56 is below the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

TC Erciyes University is the lead sponsor of 349 studies on the registry; 74 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

**Inclusion Criteria:**

  • Patients aged 18-65 years with I-II.
  • Patients who have not used analgesics or antibiotics within the previous 7 days.
  • Patients with previously root canal-treated, single-rooted permanent teeth requiring nonsurgical endodontic retreatment.
  • Teeth exhibiting radiographic evidence of loss of apical constriction or an enlarged apical foramen.
  • Patients with clinically and radiographically diagnosed apical periodontitis.
  • Teeth that are restorable and do not require extraction.

**Exclusion Criteria:**

  • Patients with diabetes mellitus, , pregnancy, or other medically compromising conditions requiring medication.
  • Patients requiring antibiotic prophylaxis.
  • Patients with known allergies to materials used during root canal treatment.
  • Patients with known allergies to analgesics or antibiotics.
  • Teeth with calcified root canals or internal or external root resorption.
  • Teeth with immature open apices.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    BioMTA+ - Manual Compaction

    Participants in this group will undergo single-visit nonsurgical endodontic retreatment. Following root canal preparation and irrigation, the entire root canal will be filled with BioMTA+, a calcium silicate-based filling material. Manual compaction will be performed using an endodontic plugger positioned approximately 1-2 mm short of the working length. The material will be compacted from the apical toward the coronal region using controlled pressure.

    Device: BioMTA+

  • Experimental
    BioMTA+ - Reverse-Rotation Compaction

    Participants in this group will undergo single-visit nonsurgical endodontic retreatment. Following root canal preparation and irrigation, the entire root canal will be filled with BioMTA+, a calcium silicate-based filling material. Compaction will be performed using a 40/.04 nickel-titanium rotary instrument operated in reverse rotation at 100 rpm. The instrument will be positioned approximately 1 mm short of the working length, and the material will be compacted using controlled movements.

    Device: BioMTA+

  • Experimental
    Well-Root PT - Manual Compaction

    Participants in this group will undergo single-visit nonsurgical endodontic retreatment. Following root canal preparation and irrigation, the entire root canal will be filled with Well-Root PT, a premixed calcium silicate-based filling material. Manual compaction will be performed using an endodontic plugger positioned approximately 1-2 mm short of the working length. The material will be compacted from the apical toward the coronal region using controlled pressure.

    Device: Well-Root PT

  • Experimental
    Well-Root PT - Reverse-Rotation Compaction

    Participants in this group will undergo single-visit nonsurgical endodontic retreatment. Following root canal preparation and irrigation, the entire root canal will be filled with Well-Root PT, a premixed calcium silicate-based filling material. Compaction will be performed using a 40/.04 nickel-titanium rotary instrument operated in reverse rotation at 100 rpm. The instrument will be positioned approximately 1 mm short of the working length, and the material will be compacted using controlled movements.

    Device: Well-Root PT

Interventions

  • DeviceBioMTA+

    BioMTA+ (Cerkamed, Poland) is a powder-liquid calcium silicate-based root canal filling material. Following single-visit nonsurgical endodontic retreatment, the material will be prepared according to the manufacturer's instructions and used to fill the entire root canal. Depending on group allocation, the material will be placed using either manual compaction or reverse-rotation compaction.

  • DeviceWell-Root PT

    Well-Root PT (Vericom, South Korea) is a premixed, ready-to-use calcium silicate-based root canal filling material. Following single-visit nonsurgical endodontic retreatment, the material will be used to fill the entire root canal. Depending on group allocation, the material will be placed using either manual compaction or reverse-rotation compaction.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Assessed Using the Visual Analog Scale (VAS)

    Postoperative pain intensity was self-recorded by participants using a numerical rating scale ranging from 0 to 100, where 0 indicated no pain and 100 indicated the worst pain imaginable. Higher scores indicated greater postoperative pain intensity. Pain scores were recorded after the second regenerative endodontic treatment visit.

    Time frame: At 6, 12, and 24 hours and daily from Day 2 through Day 7 after the second treatment visit

Secondary outcomes

  1. Postoperative Analgesic Consumption

    Participants were instructed to use paracetamol only when postoperative pain persisted. A dose of 250 to 500 mg was recommended according to the participant's age and body weight. The number of paracetamol tablets taken at each assessment time was recorded as 0, 1, or 2. Higher values indicated greater analgesic consumption.

    Time frame: At 6, 12, and 24 hours and daily from Day 2 through Day 7 after the second treatment visit

07

Study locations

1 site
  • Ercıyes Unıversıty Faculty of Dentıstry
    Kayseri, 38100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Aug 2026, 2 months.

Of 2,089 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 2 months is below that.

Counting every sponsor, half of 2,102 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Nov 2, 2026
StartActual
Jun 10, 2026
Primary completionActual
Aug 27, 2026
CompletionEst.
Oct 20, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07908394
Responsible party
Busranur Yavuz (ARŞ.GÖR, TC Erciyes University) — Principal investigator
First posted
Nov 2, 2026
Start date
Jun 10, 2026
Primary completion
Aug 27, 2026
Completion
Oct 20, 2026 (estimated)
Last update
Nov 2, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion